What was recalled
This page synthesizes the sourcing and stability framework around pantothenic acid in commercial pet food. Pantothenic acid is a water-soluble B-complex vitamin functioning as the precursor for two essential cofactors: coenzyme A (CoA), the universal acyl carrier in cellular metabolism, and acyl carrier protein (ACP), the carrier in the fatty acid synthase complex. CoA participates in the citric acid cycle (acetyl-CoA), fatty acid beta-oxidation (acyl-CoA), fatty acid synthesis (acetyl-CoA, malonyl-CoA), ketone body metabolism, cholesterol biosynthesis, steroid hormone synthesis, heme biosynthesis (succinyl-CoA), and dozens of additional acyl-transfer reactions. ACP is integral to fatty acid synthase, providing the flexible arm that shuttles growing fatty acid intermediates between catalytic domains. Without adequate pantothenic acid, essentially every cellular metabolic process requiring acyl-group transfer would be compromised. Our pantothenic acid explainer covers the basic nutritional framework.
Commercial pet food pantothenic acid sources fall into three categories. Calcium pantothenate (the calcium salt of the D-pantothenate isomer) is the dominant synthetic supplement form, produced by microbial fermentation (typically using engineered Escherichia coli or Bacillus subtilis). Calcium pantothenate is highly shelf-stable, water-soluble, and provides predictable potency. Pantothenic acid free acid is the unconjugated form, less commonly used commercially due to lower stability. Panthenol (the alcohol analog of pantothenic acid) is converted to pantothenic acid in vivo and is occasionally used in cosmetic and topical formulations but rarely in oral pet food. Naturally occurring pantothenic acid is widely distributed across animal and plant sources, with particularly high concentrations in animal liver, kidney, heart, egg yolk, mushrooms, and certain whole grains (wheat germ, rice bran). Named-meat-anchored commercial pet food contributes substantial pantothenic acid through animal tissue inclusion in addition to the supplemental calcium pantothenate.
Why it was recalled
The structural framework has two layers. Layer one — extrusion-processing loss: pantothenic acid is moderately heat-sensitive and susceptible to thermal degradation during high-temperature extrusion processing. Published commercial-formulator literature reports approximately 15-30% pantothenic acid loss across typical pet food extrusion conditions (110-180 °C, 30-180 second residence time, with subsequent drying and coating steps). The loss rate varies with specific extruder configuration, residence time, moisture content, and other formulation variables. Commercial pet food brands compensate by over-supplementing pantothenic acid at the formulation stage by 30-50% to ensure AAFCO-compliant finished-product concentration. The practice is standard across the industry and produces safe finished-product vitamin content within AAFCO bounds throughout the expected shelf life. The underlying processing loss is rarely communicated to pet owners on label or marketing material.
Layer two — shelf-life stability versus other B-vitamins: pantothenic acid is among the more stable B-vitamins under typical pet food storage conditions (less light-sensitive than riboflavin, less moisture-sensitive than thiamine). Shelf-life loss is modest relative to extrusion loss; over-supplementation primarily addresses processing loss rather than storage loss. The broader extrusion heat amino acid damage framework applies to multiple thermally sensitive nutrients including amino acids, B-vitamins, and some lipid components; pantothenic acid is one of several B-vitamins requiring formulation-stage over-supplementation to compensate for processing loss. The cumulative impact of extrusion processing on multiple thermally sensitive nutrients drives the broader practice of comprehensive vitamin and amino acid premix over-supplementation in commercial dry pet food.
Health risks for your pet
Clinical pantothenic acid deficiency in dogs and cats fed AAFCO-compliant commercial diets is essentially never seen at the population level. Pantothenic acid is widely distributed across animal and plant food sources; deficiency requires prolonged severely restricted intake. The highest theoretical risk populations are animals fed prolonged unbalanced homemade diets without nutritionist oversight and animals with severe small-intestinal malabsorption. Clinical signs of pantothenic acid deficiency include neurological signs (gait abnormality, weakness), gastrointestinal disease, skin and coat changes, and immune dysfunction. The syndrome is essentially historical in modern commercial-fed companion-animal populations.
Pantothenic acid excess from dietary sources or supplementation is essentially never seen; the vitamin has an extremely wide safety margin and excess is excreted in urine. Therapeutic high-dose pantothenic acid has limited indications in veterinary medicine. The structural concern at the population level remains processing-loss tracking and formulation-stage over-supplementation discipline rather than clinical inadequacy or excess. Pet owners feeding AAFCO-compliant commercial diets from established brands can be confident in pantothenic acid adequacy without specific attention to this micronutrient.
What to do if you bought affected product
Pet owners can manage pantothenic acid adequacy through several practical approaches: (1) for most healthy pets on AAFCO-compliant commercial diet, pantothenic acid adequacy is not a practical concern — commercial formulation with over-supplementation at the manufacturing stage routinely meets the requirement; (2) for pets on prolonged homemade diet, ensure the formulation has been balanced by a board-certified veterinary nutritionist (DACVN) — pantothenic acid is one of multiple B-vitamins requiring deliberate inclusion in homemade formulation; (3) for pets with chronic gastrointestinal disease (IBD, EPI, small-intestinal lymphoma), B-vitamin supplementation including pantothenic acid may be appropriate alongside underlying disease management; discuss with your veterinarian; (4) do not stack multiple B-complex supplements on commercial diet without veterinary indication — pantothenic acid has a wide safety margin but multivitamin stacking can produce other-nutrient over-intake (notably vitamin D, vitamin A retinol); (5) recognize that processing-loss tracking is the structural concern rather than acute deficiency — commercial pet food brands routinely over-supplement at formulation to compensate for extrusion loss; the AAFCO compliance framework operates at finished-product testing rather than at formulation; (6) watch for B-vitamin deficiency signs in chronic GI disease — coat-quality changes, neurologic signs, and immune dysfunction warrant veterinary evaluation, though primary pantothenic acid deficiency is uncommon in modern commercial-fed populations.
How this affects KibbleIQ’s grade
The KibbleIQ rubric v15 does not currently differentiate pantothenic acid source form or processing-loss compensation per our published methodology, since AAFCO-compliant commercial diets routinely meet the canine and feline requirements through standard over-supplementation at formulation. The structural framework is well-addressed at the manufacturing level; the AAFCO testing regime operates at finished-product concentration which is the consumer-relevant measure. Future rubric extension under consideration: brands publishing formulation-stage versus finished-product B-vitamin concentration with processing-loss disclosure would receive favorable transparency scoring weight; the broader pattern across thermally sensitive nutrients in extruded pet food remains a category-level transparency opportunity. The clinical relevance is modest; commercial pet food adequately addresses pantothenic acid through standard formulation discipline.